Ownership history in Candriam S.C.A. Β· 4 quarters on record
This page tracks every 13F SEC filing in which Candriam S.C.A. reported a position in SOLVENTUM CORP (SOLV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Candriam S.C.A. underperformed the S&P 500 by β4.7% annually on this SOLV position. Timing score: 67% (2/3 decisions correct). Average cost basis: $74.13. Maximum drawdown during holding period: β4.0%.
β οΈ Trailed SPY by 4.7% ann. on this position.
3 quarters analyzed
β
Decent timing β more right than wrong on entries and exits.
2 of 3 add/trim decisions correct
Best entry: $66.06 (2024 Q4) Β· Worst: $75.84 (2025 Q2)
π No drawdown exceeding 20% during the holding period β exceptionally stable.
3 adds Β· 1 trim. Bought during 2 of 2 down-price quarters. π Consistently bullish β fund kept accumulating this position.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.03% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size